Back to search

Article

Adoption and uptake of the lateral flow urine LAM test in countries with high tuberculosis and HIV/AIDS burden: current landscape and barriers

2020-04-07

Abstract excerpt

<h4>Background: </h4> Since 2015, the World Health Organization (WHO) has recommended a commercially available lateral-flow urine LAM test (Alere-LAM) to assist in the diagnosis of tuberculosis (TB) in severely ill people living with HIV (PLHIV). The test can rapidly detect TB in severely ill PLHIV and can identify PLHIV most at-risk of death, leading to mortality reductions. However, its uptake in countries with...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
73d7eb93-ce59-5bc7-aa5b-25ab90952eef
DOI
10.12688/gatesopenres.13112.2
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Adoption and uptake of the lateral flow urine LAM test in countries with high tuberculosis and HIV/AIDS burden: current landscape and barriersDOI 10.12688/gatesopenres.13112.2
A new rapid lipoarabinomannan urine assay for tuberculosis: a two-centre diagnostic accuracy evaluation in outpatients with and without HIVSemantic proximity
Diagnostic Accuracy and Yield of Determine Urine TB LF-LAM® for Detecting Tuberculosis Among Adults and Children with Advanced HIV Disease in NigeriaSemantic proximity
Point-of-Care Urine LAM Tests for Tuberculosis Diagnosis: A Mini-ReviewSemantic proximity
REVISITING TUBERCULOSIS (TB) DIAGNOSIS: THE PROSPECT OF URINE LIPOARABINOMANNAN (LAM) ASSAY AS A DIAGNOSTIC TOOL IN PEOPLE LIVING WITH HIVSemantic proximity
Implementation of Point of Care HIV Viral load monitoring for people living with HIV in Low and Middle-income Countries: A systematic review on implementation research outcomesSemantic proximity
Market penetration of Xpert MTB/RIF in high tuberculosis burden countries: A trend analysis from 2014 - 2016Semantic proximity
Challenges with Scale-up of GeneXpert MTB/RIF® inUganda: a Health Systems PerspectiveSemantic proximity
Point-of-care C-reactive protein and Xpert MTB/RIF Ultra for tuberculosis screening and diagnosis in unselected antiretroviral therapy initiators: a prospective diagnostic accuracy studySemantic proximity
Determine TB –LAM Lateral Flow Assay, Does M. tuberculosis lineage influence its performance?Semantic proximity
High initiation but sub-optimal completion of tuberculosis preventive treatment among people living with HIV on ART, persistent tuberculosis incidence and programmatic implications: Findings from a two-year multi-country cohort studySemantic proximity
Implementation of a rapid diagnostic assay package for Cryptococcosis, Histoplasmosis and Tuberculosis in People Living with HIV in ParaguaySemantic proximity
USING SPUTUM AND TONGUE SWAB SPECIMENS FOR IN-HOME POINT-OF-CARE TARGETED UNIVERSAL TESTING FOR TB OF HOUSEHOLD CONTACTS: AN ACCEPTABILITY AND FEASIBILITY ANALYSISSemantic proximity
Select a neighboring publication to make it the new centre.